OTC · Drug Manufacturers - Specialty & Generic

The Hempshire Group, Inc. (HMPSF) Stock

$0.19 +0.00% OTC: HMPSF Healthcare

The Hempshire Group, Inc. specializes in the full lifecycle of pharmaceutical-grade hemp and CBD products, encompassing their acquisition, production, branding, and refinement.

Valuation

MetricValue
Price$0.19
Market Cap$15.68M
P/E Ratio-1.97
P/B Ratio12.83
P/S Ratio176.05
EPS (TTM)$-0.10
52-Week High$0.20
52-Week Low$0.19
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-700.00%
ROA-454.97%
ROCE-255.11%
Gross Margin28.77%
Operating Margin—
Net Margin—
Debt/Equity0.01
Current Ratio2.52

Annual Financials (USD)

Metric202020212022
Revenue$0$0$0
Operating Profit$0$-2.0M$-3.0M
Net Profit$0$-2.0M$-7.0M
EPS$-0.03$-0.03$-0.10
Op Margin-96.9%-607.0%-2855.0%

Balance Sheet (USD)

Metric202020212022
Total Assets$0$1.0M$1.0M
Total Liabilities$0$2.0M$0
Cash$0$0$0
Borrowings$0$1.0M$0

Latest News

Mortgage rates rose again amid renewed tensions with Iran Yahoo Finance · Jul 16, 2026 Target recalls 211K children's sandals. See affected products USA TODAY · Jul 16, 2026 3 Stocks Under $50 We Keep Off Our Radar StockStory · Jul 16, 2026 Freddie Mac says the average rate on a 30-year mortgage rose to 6.55% this week, its highest level since August Associated Press · Jul 16, 2026 Blast Resources Announces Strong Uranium/Thorium Anomalies on Britts Lake Claims in Athabasca Basin Region, Saskatchewan CNW Group · Jul 16, 2026

Cash Flow (USD)

Metric202020212022
Operating Cash Flow$0$-1.0M$-3.0M
Investing Cash Flow$0$0$0
Financing Cash Flow$0$0$0
Net Cash Flow$0$0$0
Free Cash Flow$0$-1.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA-2.49
FCF Yield-19.59%
Quick Ratio1.31
Interest Coverage-10.32
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMHVAmerican Hemp Ventures, Inc. $0.98 +0.00% — $16.47M 0.00%
ATHJFAntisense Therapeutics Limited $0.01 -76.00% -1.00 $19.64M 0.00%
BFFTFBiofrontera AG $0.33 -95.24% -0.97 $19.35M 0.00%
GRAMFTPCO Holding Corp. $0.16 -15.36% -0.07 $20.12M 0.00%
MGCLFMGC Pharmaceuticals Limited $0.27 +2.88% -0.06 $12.11M 0.00%

About The Hempshire Group, Inc.

The Hempshire Group, Inc. specializes in the full lifecycle of pharmaceutical-grade hemp and CBD products, encompassing their acquisition, production, branding, and refinement. Established in 2019, this company operates from its base in Palm Springs, California.

The Hempshire Group, Inc. is headquartered in US.

The Hempshire Group, Inc. (HMPSF) stock trades at $0.19 with a market capitalization of $15.68M. The stock is valued at a price-to-earnings (P/E) ratio of -1.97, price-to-book of 12.83, price-to-sales of 176.05. Over the past 52 weeks the stock has ranged between $0.19 and $0.20, and currently trades 5.0% below its 52-week high.

On profitability, The Hempshire Group, Inc. generates a return on equity (ROE) of -700.00%, return on capital employed of -255.11%.

Official website: mountainsmokes.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides